1000/1000
Hot
Most Recent
Interval training (IT) is a popular training strategy recognized by its positive effects on metabolic and cardiovascular system. However, there seems no consensus regarding the effects of IT on immune system parameters. Therefore, researchers aimed to summarize the evidence regarding the effects of IT on the immune system. As our many findings, an IT acutely promote a transitory change on immune cell count followed by reduced function. The magnitude of these changes seems to vary in accordance with IT type. On the other hand, the regular practice of IT might contribute to improve immune function without apparent change on immune cell count.
Study | Participants | Design | Modality/Interval Protocol | Results |
---|---|---|---|---|
Monje et al. 2020 [34] | 20 runners (10 men age: 21.9 ± 0.8 years; 10 women age: 25.8 ± 6.2 years) | Clinical trial | Running HIIT—10 bouts of 4 min at 90% of vV˙O2max interspersed by 2 min of passive recovery |
↑ salivary IgA concentration 20 min after exercise |
Wahl et al. 2020 [35] 12 men triathletes and cyclists (age: 24.7 ± 3.4 years) Randomized cross-over trial |
Cycling HIIT—4 bouts of 4 min at 90–95% of peak power interspersed by 3 min of passive recovery |
↔ leucocyte count; ↓ lymphocyte count 30 min, and 60 min after exercise; ↑ neutrophil count 180 min after exercise; ↔ mixed cell count | ||
Cycling HIIT—4 bouts of 4 min at 90–95% of peak power interspersed by 3 min at 45% of peak power |
↔ leucocyte count; ↑ lymphocyte count immediately after exercise followed by ↓ 30 min, 60 min and 180 min after exercise; ↑ neutrophil count 60 min and 180 min after exercise; ↔ mixed cell count | |||
Cycling SIT—4 bouts of 30 s “all-out” effort interspersed by 7.5 min passive recovery |
↑ leucocyte count immediately, and 180 min after exercise; ↑ lymphocyte count immediately after exercise followed by ↓ 60 min and 180 min after exercise; ↑ neutrophil count 60 min and 180 min after exercise; ↑ mixed cell count immediately after exercise | |||
Cycling SIT—4 bouts of 30 s “all-out” effort interspersed by 7.5 min at 45% of peak power |
↑ leucocyte count immediately, and 180 min after exercise; ↑ lymphocyte count immediately after exercise followed by ↓ 30 min, 60 min, and 180 min after exercise; ↑ neutrophil count 60 min, and 180 min after exercise; ↔ mixed cell count | |||
De Oliveira Ottone et al. 2019 [36] | 12 inactive health men (age: 22.5 ± 3.9 years) | Clinical trial | Cycling HIIT—8 bouts of 60 s at 90% peak power interspersed by 75 s of active recovery (30 watts) |
↓ neutrophil oxidative burst in response to f-PMN 30 min after exercise; ↑ neutrophil phagocytic capacity, oxidative burst and redox status 24 h after exercise |
Jamurtas et al. 2018 [37] | 12 health men (age: 22.4 ± 0.5 years) | Randomized cross-over trial | Cycling SIT—4 bouts of 30 s “all-out” effort interspersed by 4 min of active recovery |
↑ leucocyte count immediately after exercise |
Souza et al. 2018 [38] | 10 obese men (age: 28.5 ± 2.7 years) | Randomized cross-over trial | Running HIIT—10 bouts of 1 min at 90% of Vmax interspersed by 1 min at 30% of Vmax |
↔ secretory IgA and IgA concentration |
Rodrigues de Araujo et al. 2018 [39] | 32 men soccer players (age: 21.2 ± 4.2 years) | Clinical trial | Running SIT—7 bouts of 40 m “all-out” effort with direction changes interspersed by 25 s of active recovery (light jogging) |
↔ IgA concentration |
Belviranli et al. 2017 [40] | 10 inactive health men (age: 20.0 ± 1.33 years) | Clinical trial | Cycling SIT—4 bouts of 30 s “all-out” effort interspersed by 4 min of active recovery (the load was determined according with the Monark Anaerobic Test Software) |
↑ leucocyte count immediately, 3h, and 6 h after exercise; ↑ lymphocyte count immediately after exercise followed by ↓ lymphocyte count 3 h, and 6 h after exercise; ↑ neutrophil count 3 h, and 6 h after exercise; ↔ monocyte count; ↑ eosinophil count immediately after exercise followed by ↓ 3 h, and 6 h after exercise; ↑ basophil count immediately after exercise |
Krüger et al. 2016 [41] | 23 untrained health men (age: 25.7 ± 3.2 years) | Randomized cross-over trial | Cycling HIIT—5 bouts of 3 min at 90% peak power output interspersed by 3 min of active recovery (without resistance) |
↑ lymphocyte CD3+, CD4+ and CD8+ count immediately, and 3 h after exercise; ↑ mobilization of low differentiated T cells, regulatory T cells and progenitor cells; ↑ apoptosis in high differentiated T cells |
Tossige-Gomes et al. 2016 [42] | 10 inactive health men (age: 23.7 ± 1.1) | Clinical trial | Cycling HIIT—8 bouts of 1 min at 100% of peak power interspersed by 75 s of active recovery at 30 W |
↑ lymphocyte redox imbalance 30 min after exercise; ↓ lymphocyte proliferation in response to antigenic, but not to mitogenic stimulation immediately and 30 min after exercise |
6 inactive health men (age: 21.3 ± 1.8 years) | Cycling HIIT—8 bouts of 1 min at 100% of peak power interspersed by 75 s of active recovery at 30 W |
↔ lymphocyte viability | ||
Turner et al. 2016 [43] | 9 health men (age: 22.1 ± 3.4 years) | Randomized cross-over trial | Cycling HIIT—10 bouts of 1 min at 90% of V˙O2max interspersed by 1 min at 40% of V˙O2max |
↑ leucocyte, lymphocyte count immediately after exercise; mobilization of cutaneous lymphocyte natural killer and lymphocyte CD8+ to blood |
Dorneles et al. 2016 [44] | 12 overweight-obese men (age: 27.41 ± 9.20 years) | Randomized cross-over trial | Running HIIT—10 bouts of 1 min at 85–90% maximum power output interspersed by 75 s at 50% maximum power output |
↑ leucocyte, lymphocyte, and monocyte count immediately after exercise |
10 lean men (age: 26.5 ± 6.11 years) | Running HIIT—10 bouts of 1 min at 85–90% maximum power output interspersed by 75 s at 50% maximum power output |
↑ leucocyte immediately and 30 min after exercise; ↑lymphocyte and monocyte immediately after exercise | ||
Arroyo-Morales et al. 2012 [45] | 50 active health subjects, 25 men (age: 22.4 ± 3.42 years) | Clinical trial | Arm-cycling SIT—3 bouts of 30 s “all-out” effort interspersed by 3 min (90 s of active recovery at 50% W work rate and 90 s of passive recovery) |
↔ secretory IgA |
Friedman et al. 2012 [46] | 8 health subjects, 4 men (age: 24) | Clinical trial | SIT—2 sets of 3 bouts of 30 s “all-out” effort interspersed by 2 min of active recovery. Sets were separated by 6.75 min | ↑ lymphocyte CD8+, and CD8+/CD45RA+ count and ↑ lymphocyte CD8+, and CD8+/CD45RA+ migration immediately after exercise. ↑ lymphocyte CD8+, and CD8+/CD45RA+ count and ↔ lymphocyte CD4+, and CD4+/CD45RA+ migration immediately after exercise |
Fisher et al. 2011 [33] | 8 active health men (age: 22 ± 2 years) | Clinical trial | Cycling HIIT—4 bouts with 30 s at 90% of maximum anaerobic power interspersed by 4 min of active recovery at 15% of maximum anaerobic power |
↑ leucocyte and neutrophil counts immediately and 3 h after exercise; ↑ lymphocyte count immediately after exercise; ↓ lymphocyte cell viability 3 h after exercise |
Davison 2011 [47] | 9 active health men (age: 27 ± 5 years) | Randomized cross-over trial | Cycling SIT—4 bouts of 30 s “all-out” effort interspersed by 4 min of active recovery with light loads |
↔ secretory IgA and ↑ IgA concentration; ↑ neutrophil count immediately and 30 min after exercise; ↓ neutrophil oxidative burst in response to fMLP 30 min after exercise |
Thomas et al. 2010 [48] | 10 health adolescent women (age 15.5 ± 0.6 years) | Clinical trial | Cycling SIT—8 bouts of 8 s “all-out” effort interspersed by 30 s of passive recovery |
↔ IgA concentration 5 min after exercise |
Fahlman et al. 2001 [49] | 26 active health women (age: 24.2 ± 5.8 years) | Clinical trial | Cycling SIT—3 bouts of 30 s “all out” effort interspersed by 3 min (90 s of active recovery pedaling against light load and 90 s of passive recovery) |
↓ secretory IgA and ↔ IgA concentration 5 min after exercise |
Walsh 1999 [50] | 8 trained men (age: 25 ± 1 years) | Clinical trial | Cycling HIIT –20 bouts of 1 min at 100% of V˙O2max interspersed by 2 min at 30% of V˙O2max |
↔ secretory IgA and IgA concentration after exercise |
Walsh et al. 1998 [51] | 8 trained men (age: 25 ± 3 years) | Clinical trial | Cycling HIIT—20 bouts of 1 min at 100% of V˙O2max interspersed by 2 min at 30% of V˙O2max |
↑ leucocytes and neutrophil count 5 min, 1 h, 2.5 h, and 5 h after exercise; ↑ lymphocyte count immediately after exercise followed by ↓ 1 h after exercise |
Hinton et al. 1997 [52] | 5 men runners (age: 23.0 ± 2.5 years) | Clinical trial | Running HIIT—15 bouts of 1 min at 90% of V˙O2max interspersed by 2 min of passive recovery |
↓ lymphocyte function immediately after exercise |
Kargotich et al. 1997 [53] | 8 high performance men swimmers (age: 19.9 ± 2.2 years) | Clinical trial | Swimming HIIT—15 bouts of 100 m freestyle swimming interspersed by 2 min 25 m recovery swim |
↑ leucocyte and neutrophil count immediately after exercise; ↑ lymphocyte count immediately after exercise followed by ↓ 1 h, 2 h, and 2.5 h after exercise; ↑ monocyte count immediately and 30 min after exercise; ↔ eosinophil count |
Gray et al. 1993 [54] | 8 men triathletes (age: 31.5 ± 4.5 years) | Clinical trial | Running HIIT—1 min at 100% of vV˙O2max interspersed by 1 min of active recovery until the exhaustion |
↑ leucocyte and lymphocyte count immediately after exercise; ↑ granulocyte and monocyte count 6 h after exercise |
Mackinnon & Jerkin, 1993 [32] | 12 active health men (age: 17 to 25 years) | Clinical trial | Cycling SIT—5 bouts of 1 min “all out” effort interspersed by 5 min of passive recovery |
↓ secretory IgA and ↑ IgA concentration immediately after exercise |
Fry et al. 1992 [55] | 14 men runners (age: 18–25 years) | Clinical trial | Running Treadmill HIIT—25 bouts of 1 min at one stage before that which the subject failed in the preliminary test) followed by 2 min active recovery |
↓ lymphocyte proliferative response immediately after exercise |
18 men kayakists (age: 18–25 years) | Paddling HIIT—25 bouts of 1 min at one stage before that which the subject failed in the preliminary test interspersed by 2 min of active recovery |
↓ lymphocyte proliferative response immediately after exercise | ||
Fry et al. 1992 [56] | 7 men runners (age: 22.9 ± 5.6 years) | Cross-over clinical trial | Running HIIT—15 bouts of 1 min at 90% of Vmax interspersed by 2 min of active recovery |
↔ leucocytes, lymphocyte, neutrophil and monocyte count 5 min after exercise. ↔ the CD4+:CD8+ ratio and responsiveness of T cells to T cells mitogens |
Running HIIT—15 bouts of 1 min at 120% of Vmax interspersed by 2 min of active recovery |
↑ leucocytes count, lymphocyte, neutrophil, monocyte count 5 min after exercise. ↓ the CD4+:CD8+ ratio and responsiveness of T cells to mitogens immediately after exercise |
Study | Participants | Duration/Design | Modality/Interval Protocol | Results |
---|---|---|---|---|
Bartlett et al. 2020 [57] | 10 subjects with prediabetes, 4 men (age: 71 ± 5 years) | Ten weeks clinical trial | Walking HIIT—60–90 s at 80–90% of V˙O2 reserve interspersed by 60–90 s of active recovery at 50–60% of VO2 reserve until complete 20 min. Frequency: 3 times per week. Supervised: Yes |
↑ neutrophil chemotaxis, mitogen stimulated ROS production and ↓ basal ROS production. ↔ neutrophil count |
Toohey et al. 2020 [58] | 6 breast cancer survivors (age: 60 ± 8.12 years) | Twelve weeks randomized clinical trial | Cycling SIT—4 to 7 bouts of 30 s “all-out” effort interspersed by 2 min of active recovery. Frequency: 3 times per week. Supervised: Yes |
↔ IgA concentration |
Dorneles et al. 2019 [30] | 7 sedentary obese men (age: 20 to 40 years) | One-week clinical trial | Running HIIT—10 bouts of 1 min at 85–90% maximum heart rate interspersed by 75 s at 50% maximum heart rate. Frequency: 3 times per week. Supervised: No reported |
↑ circulating of memory regulatory T cells and regulatory T cells |
Werner et al. 2019 [31] | 29 inactive health subjects, 10 men (age: 48.4 ± 6.5 years) | Twenty-six weeks randomized controlled trial | Running HIIT—4 bouts of 4 min at 80–90% of heart rate reserve interspersed by 3 min at 65–70% of heart rate reserve. Frequency: 3 times per week. Supervised: No reported |
↔ total leucocyte counts (lymphocyte, neutrophil and monocyte); ↑ leucocyte telomerase length (lymphocyte, granulocyte) |
Khammassi et al. 2020 [59] | 8 active health young adults (age: 18.9 ± 1.0 years) | Nine weeks randomized clinical trial | Running HIIT—3 sets of 6 to 8 30-s bouts at 100 to 110% of Vmax and 30 s of active recovery at 50% of Vmax. Frequency: 3 times per week. Supervised: No reported |
↔ total leucocyte counts (lymphocyte, neutrophil and monocyte) |
Bartlett et al. 2018 [60] | 12 inactive elderly subjects with rheumatoid arthritis (age: 64 ± 7 years) | Ten weeks clinical trial | Walking HIIT—60–90 s at 80–90% of V˙O2 reserve interspersed by active recovery with similar duration at 50–60% of VO2 reserve until complete 20 min of session. Frequency: 3 times per week. Supervised: Yes |
↑ neutrophil function |
Sheykhlouvand et al. 2018 [61] | 7 men canoe polo athletes (age: 24 ± 3 years) | Three weeks randomized clinical trial | Paddling HIIT—6 bouts of 1 min at 100 to 130% vV˙O2peak with 1:3 work to recovery ratio. Frequency: 3 times per week. Supervised: No reported |
↔ leucocyte counts |
7 men canoe polo athletes (age: 24 ± 3 years) | Paddling HIIT—6 to 9 bouts of 1 min at 100% vV˙O2peak with 1:3 work to recovery ratio. Frequency: 3 times per week. Supervised: No reported |
↔ leucocyte counts | ||
Bartlett et al. 2017 [62] | 14 inactive health adults (age: 43 ± 11 years) | Ten weeks randomized clinical trial | Cycling HIIT—15 to 60 s above 90% of maximum heart rate interspersed by 45–120 s of active recovery until complete 18–25 min. Frequency: 3 times per week. Supervised: Yes |
↑ neutrophil and monocyte function |
Tsai et al. 2016 [63] | 20 inactive health men (age: 23.0 ± 1.7 years) | Six weeks randomized clinical trial | Cycling HIIT—5 bouts of 3 min at 80% of V˙O2max interspersed by 3 min of active recovery at 40% of V˙O2max. Frequency: 5 times per week. Supervised: No reported |
↑ lymphocyte function |
Navalta et al. 2014 [29] | 12 subjects, 8 men (age: 26 ± 4 years) | Three consecutive days clinical trial | Running HIIT—30 s at 100% of Vmax interspersed by active recovery with similar duration at 50% of Vmax until exhaustion. Frequency: 3 times per week. Supervised: No reported |
↑ lymphocyte apoptosis |
Fisher et al. 2011 [33] | 8 active health men (age: 22 ± 2 years) | One-week clinical trial | Cycling HIIT—4 bouts with 30 s at 90% of maximum anaerobic power interspersed by 4 min of active recovery at 15% of maximum anaerobic power. Frequency: 3 times per week. Supervised: No reported |
↑ lymphocyte function |
Mackinnon & Jerkin, 1993 [32] | 12 active health men (age: 17 to 25 years) | Eight weeks clinical trial |
Cycling SIT—5 bouts of 1 min “all out” effort interspersed by 5 min of passive recovery. Frequency: 3 times per week. Supervised: Yes |
↔ secretory IgA and IgA concentration |
Reference | Study Quality | Score (0–5) |
Study Reporting | Score (0–10) |
Total Score (0–15) |
Study Quality Classification |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6a | 6b | 6c | 7 | 8a | 8b | 9 | 10 | 11 | 12 | |||||
Khammassi et al. [59] | + | − | + | + | − | 3 | − | − | − | − | − | − | + | NA | − | + | 2 | 5 | Low |
Toohey et al. [58] | + | + | + | − | + | 4 | + | − | + | − | + | + | + | − | + | + | 7 | 11 | High |
Wahl et al. [35] | − | − | − | − | − | 0 | − | − | − | − | + | + | + | NA | − | + | 4 | 4 | Low |
Dorneles et al. [30] | + | − | − | − | − | 1 | − | − | − | − | − | − | + | NA | + | + | 3 | 4 | Low |
Werner et al. [31] | + | − | + | + | − | 3 | − | − | − | − | + | + | + | − | − | + | 4 | 7 | Low |
de Souza et al. [38] | + | + | − | − | − | 2 | − | − | − | − | + | + | + | − | − | + | 4 | 6 | Low |
Jamurtas et al. [37] | − | − | − | − | − | 0 | − | − | − | − | − | − | + | NA | − | + | 2 | 2 | Low |
Sheykhlouvand et al. [61] | + | − | + | − | − | 2 | − | − | − | − | − | − | + | NA | − | + | 2 | 4 | Low |
Bartlett et al. [62] | − | − | + | + | − | 2 | − | − | − | − | − | − | + | NA | − | + | 2 | 4 | Low |
Krüger et al. [41] | + | − | − | − | − | 1 | − | − | − | − | − | − | − | NA | − | + | 1 | 2 | Low |
Tsai et al. [63] | + | − | − | − | − | 1 | + | − | + | − | + | + | + | + | + | + | 8 | 9 | Fair |
Turner et al. [43] | − | − | − | − | − | 0 | − | − | + | − | − | − | + | NA | − | + | 3 | 3 | Low |
Davison. [47] | − | − | − | − | − | 0 | − | − | − | − | + | + | + | − | − | − | 3 | 3 | Low |
Outcome (Subgroup) | N° of Studies | MD (95% CI) | p-Value | Heterogeneity | |
---|---|---|---|---|---|
I2 (%) |
p-Value | ||||
IgA concentration (µg·mL−1) | |||||
IT type: SIT | 5 | 46.98 (56.73 to 150.68) | 0.37 | 94 | <0.001 |
IT type: HIIT | 4 | 39.54 (19.92 to 59.16) | <0.001 | 0 | 1 |
Sex: men | 6 | 65.62 (−6.43 to 137.66) | 0.07 | 91 | <0.001 |
Sex: women | 3 | −18.91 (−66.24 to 28.42) | 0.43 | 0 | 0.59 |
Modality: cycling | 5 | 53.22 (−33.53 to 139.96) | 0.23 | 94 | <0.001 |
Modality: running | 4 | 22.07 (−17.34 to 61.47) | 0.27 | 0 | 0.92 |
IgA secretory rate (µg·min−1) | |||||
IT type: SIT | 6 | −17.33 (−33.68 to −0.98) | 0.03 | 68 | 0.007 |
IT type: HIIT | 2 | −7.29 (−23.95 to 9.36) | 0.39 | 0 | 0.73 |
Sex: men | 5 | −13.17 (−35.03 to 8.70) | 0.24 | 74 | 0.004 |
Sex: women | 2 | −19.34 (−29.11 to −9.58) | <0.001 | 0 | 0.74 |
Modality: cycling | - | - | - | - | - |
Modality: running | - | - | - | - | - |
Leucocyte count (103 µL−1) | |||||
IT type: SIT | 5 | 3.14 (1.83 to 4.44) | <0.01 | 80 | <0.001 |
IT type: HIIT | 9 | 2.31 (1.30 to 3.32) | <0.001 | 78 | <0.001 |
Sex: men | - | - | - | - | - |
Sex: women | - | - | - | - | - |
Modality: cycling | 9 | 2.40 (1.47 to 3.33) | <0.001 | 84 | <0.001 |
Modality: running | 3 | 2.46 (1.30 to 3.62) | <0.001 | 21 | 0.28 |
Lymphocyte count (103 µL−1) | |||||
IT type: SIT | 3 | 1.62 (0.89 to 2.35) | <0.001 | 66 | 0.05 |
IT type: HIIT | 9 | 1.21 (0.67 to 1.74) | <0.001 | 81 | <0.001 |
Sex: men | - | - | - | - | - |
Sex: women | - | - | - | - | |
Modality: cycling | 8 | 1.17 (0.65 to 1.70) | <0.001 | 82 | <0.001 |
Modality: running | 3 | 1.14 (0.67 to 1.61) | <0.001 | 10 | 0.33 |
Lymphocyte count (103 µL−1) recovery | |||||
IT type: SIT | 3 | −0.51 (−0.77 to −0.26) | <0.001 | 18 | 0.30 |
IT type: HIIT | 9 | −0.29 (−0.56 to 0.03) | 0.03 | 66 | 0.003 |
Sex: men | - | - | - | - | - |
Sex: women | - | - | - | - | - |
Modality: cycling | 8 | −0.47 (−0.62 to −0.32) | <0.001 | 0 | 0.55 |
Modality: running | 3 | 0.04 (−0.63, 0.72) | 0.9 | 85 | 0.001 |